$IRTC·8-K

iRhythm Holdings, Inc. · Jun 5, 7:47 AM ET

Compare

iRhythm Holdings, Inc. 8-K

Research Summary

AI-generated summary

Updated

iRhythm Holdings Announces $45M Settlement of Securities Class Action

What Happened
iRhythm Holdings, Inc. disclosed on June 5, 2026 (agreement dated June 3, 2026) that its wholly owned subsidiary, iRhythm Technologies, Inc., entered into a binding Stipulation and Agreement of Settlement to resolve the putative securities class action Glazing Employers and Glaziers' Union Local #27 Pension and Retirement Fund v. iRhythm Technologies, Inc., Case No. 3:24-cv-706-JSC (N.D. Cal.). The settlement calls for a $45 million payment (inclusive of lead plaintiff’s attorneys’ fees and expenses) in exchange for dismissal with prejudice and a release of claims against iRhythm Tech and CEO/President Quentin Blackford, with no admission of wrongdoing. The proposed settlement is subject to court approval and a motion for preliminary approval has been filed.

Key Details

  • Settlement payment: $45.0 million (inclusive of lead counsel fees and expenses).
  • Date of agreement: June 3, 2026; 8-K filed June 5, 2026 (signed June 4, 2026 by CFO Daniel Wilson).
  • Parties: iRhythm Technologies, Inc. and CEO/President Quentin Blackford are named defendants; plaintiffs are the Glazing Employers and Glaziers' Union Local #27 Pension and Retirement Fund (Case No. 3:24-cv-706-JSC).
  • Insurance coverage: Company expects a majority of the payment will be covered by directors & officers insurance; after payment, no amounts will remain available to iRhythm Tech under the policies for this matter.
  • Does not resolve separate stockholder derivative lawsuits pending on behalf of iRhythm Tech.

Why It Matters
The $45M settlement resolves the cited securities class action if approved by the court, removing litigation uncertainty and avoiding further legal costs. Management expects most of the cost to be paid by D&O insurers, which limits direct cash impact, and the company states it does not expect the settlement to affect its non-GAAP metrics (adjusted EBITDA, adjusted net income/loss, or adjusted operating expenses). However, insurer limits will be exhausted for this matter and separate derivative suits remain unresolved, which investors should monitor for potential further impact.

Loading document...